X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2900) 2900
Publication (190) 190
Book Review (71) 71
Newsletter (37) 37
Magazine Article (9) 9
Book Chapter (4) 4
Trade Publication Article (3) 3
Book / eBook (1) 1
Data Set (1) 1
Dissertation (1) 1
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
sertraline (1953) 1953
humans (1621) 1621
pharmacology & pharmacy (1402) 1402
male (1192) 1192
psychiatry (1079) 1079
female (1000) 1000
adult (798) 798
index medicus (715) 715
fluoxetine (707) 707
middle aged (615) 615
antidepressants (574) 574
serotonin uptake inhibitors - therapeutic use (556) 556
depression (494) 494
neurosciences (481) 481
paroxetine (472) 472
animals (448) 448
serotonin uptake inhibitors - pharmacology (438) 438
sertraline - therapeutic use (438) 438
double-blind (435) 435
sertraline - pharmacology (395) 395
clinical neurology (387) 387
treatment outcome (379) 379
antidepressive agents - therapeutic use (346) 346
serotonin uptake inhibitors - adverse effects (334) 334
aged (329) 329
serotonin reuptake inhibitors (329) 329
serotonin (318) 318
double-blind method (302) 302
depressive disorder - drug therapy (299) 299
major depression (299) 299
1-naphthylamine - analogs & derivatives (294) 294
adolescent (291) 291
rats (277) 277
dose-response relationship, drug (257) 257
fluvoxamine (256) 256
drug therapy (245) 245
efficacy (238) 238
sertraline - adverse effects (225) 225
antidepressive agents - pharmacology (220) 220
depressive disorder, major - drug therapy (220) 220
psychiatric status rating scales (215) 215
citalopram (213) 213
drug interactions (206) 206
serotonin uptake inhibitors (202) 202
medicine & public health (195) 195
placebo (189) 189
serotonin uptake inhibitors - administration & dosage (189) 189
pharmacology (182) 182
depression - drug therapy (181) 181
sertraline - administration & dosage (179) 179
antidepressant (178) 178
depression, mental (178) 178
pharmacology/toxicology (168) 168
sertraline, adverse reactions (168) 168
antidepressive agents - adverse effects (165) 165
major depressive disorder (160) 160
pharmacokinetics (155) 155
research (151) 151
drugs (147) 147
venlafaxine (145) 145
dosage and administration (144) 144
fluoxetine - pharmacology (144) 144
child (141) 141
time factors (141) 141
1-naphthylamine - pharmacology (140) 140
pharmacotherapy (138) 138
ssri (138) 138
analysis (133) 133
risk factors (130) 130
anxiety (126) 126
obsessive-compulsive disorder (126) 126
fluoxetine - therapeutic use (124) 124
1-naphthylamine - therapeutic use (123) 123
care and treatment (122) 122
drug therapy, combination (122) 122
mice (122) 122
imipramine (121) 121
young adult (121) 121
brain (120) 120
antidepressive agents, second-generation - therapeutic use (119) 119
mental depression (118) 118
children (117) 117
placebo-controlled trial (117) 117
article (116) 116
paroxetine - pharmacology (115) 115
rats, sprague-dawley (114) 114
toxicology (110) 110
pediatrics (109) 109
amitriptyline (107) 107
health aspects (106) 106
paroxetine - therapeutic use (106) 106
selective serotonin reuptake inhibitors (106) 106
antidepressive agents - administration & dosage (103) 103
psychopharmacology (102) 102
complications and side effects (101) 101
antidepressive agents, second-generation - adverse effects (100) 100
clinical trials (100) 100
depressive disorder - psychology (98) 98
serotonin uptake inhibitors - pharmacokinetics (97) 97
adolescents (96) 96
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2884) 2884
Japanese (20) 20
German (12) 12
Spanish (9) 9
Turkish (8) 8
French (6) 6
Russian (6) 6
Polish (3) 3
Chinese (2) 2
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Pharmacology, ISSN 0014-2999, 03/2012, Volume 679, Issue 1-3, pp. 68 - 74
Journal Article
by Booth, R and Kim, H
Annals of Biomedical Engineering, ISSN 0090-6964, 12/2014, Volume 42, Issue 12, pp. 2379 - 2391
Journal Article
The Journal of Clinical Pharmacology, ISSN 0091-2700, 12/2006, Volume 46, Issue 12, pp. 1426 - 1438
Cytochrome P450 2B6 (CYP2B6) is involved in the metabolism of drugs such as bupropion, efavirenz, propofol, and selegiline, among others. More than 200... 
HPLC/MS/MS | P450 2B6 | rhCYP2B6 | Drug‐drug interactions | in vitro | Drug-drug interactions | In vitro | Raloxifene Hydrochloride - pharmacology | Cytochrome P-450 Enzyme Inhibitors | Humans | Microsomes, Liver - metabolism | Sertraline - chemistry | Bupropion - analogs & derivatives | Cytochrome P-450 Enzyme System - metabolism | Antifungal Agents - chemistry | Xenobiotics - pharmacology | Reverse Transcriptase Inhibitors - chemistry | Xenobiotics - classification | Clotrimazole - metabolism | Platelet Aggregation Inhibitors - pharmacology | Oxazines - pharmacology | Antifungal Agents - pharmacology | Itraconazole - metabolism | Serotonin Uptake Inhibitors - metabolism | Clotrimazole - pharmacology | Serotonin Uptake Inhibitors - chemistry | Antidepressive Agents, Second-Generation - pharmacology | Clotrimazole - chemistry | Itraconazole - chemistry | Selective Estrogen Receptor Modulators - metabolism | Ticlopidine - analogs & derivatives | Raloxifene Hydrochloride - metabolism | Platelet Aggregation Inhibitors - chemistry | Oxazines - chemistry | Kinetics | Serotonin Uptake Inhibitors - pharmacology | Selective Estrogen Receptor Modulators - pharmacology | Bupropion - metabolism | Ticlopidine - pharmacology | Area Under Curve | Reverse Transcriptase Inhibitors - pharmacology | Ticlopidine - chemistry | Benzoxazines | Xenobiotics - pharmacokinetics | Itraconazole - pharmacology | Oxazines - metabolism | Microsomes, Liver - drug effects | Antifungal Agents - metabolism | Ticlopidine - metabolism | Molecular Structure | Platelet Aggregation Inhibitors - metabolism | Sertraline - metabolism | Sertraline - pharmacology | Selective Estrogen Receptor Modulators - chemistry | Algorithms | Bupropion - pharmacology | Reverse Transcriptase Inhibitors - metabolism | Antidepressive Agents, Second-Generation - metabolism | Raloxifene Hydrochloride - chemistry | Cytochrome P-450 CYP2B6 | Cytochromes | Research | Health aspects | Drug interactions
Journal Article
Neuropharmacology, ISSN 0028-3908, 04/2014, Volume 79, pp. 222 - 233
Journal Article
Journal Article
Neuropsychopharmacology, ISSN 0893-133X, 05/2009, Volume 34, Issue 6, pp. 1467 - 1481
Previous work has shown that repeated desipramine treatment causes downregulation of the norepinephrine transporter (NET) and persistent antidepressant-like... 
P-chlorophenylalanine | Norepinephrine transporter | Serotonin transporter | Antidepressant drugs | DESIPRAMINE TREATMENT | antidepressant drugs | PSYCHIATRY | DOWN-REGULATION | REBOXETINE TREATMENT | REUPTAKE INHIBITORS | IMMOBILIZATION STRESS | p-chlorophenylalanine | NEUROSCIENCES | HYDROXYLASE MESSENGER-RNA | norepinephrine transporter | serotonin transporter | RAT FRONTAL-CORTEX | MONOAMINE-OXIDASE INHIBITORS | IN-VIVO | CATECHOLAMINE DEPLETION | PHARMACOLOGY & PHARMACY | Depression - physiopathology | Phenelzine - pharmacology | Male | RNA, Messenger - metabolism | Brain - metabolism | Depression - drug therapy | Serotonin Plasma Membrane Transport Proteins - genetics | Norepinephrine Plasma Membrane Transport Proteins - genetics | Cyclohexanols - pharmacology | Protein Synthesis Inhibitors - pharmacology | Fenclonine - pharmacology | Monoamine Oxidase Inhibitors - pharmacology | Sertraline - pharmacology | Morpholines - pharmacology | Rats | Antidepressive Agents, Second-Generation - pharmacology | Down-Regulation - drug effects | Serotonin Antagonists - pharmacology | Rats, Sprague-Dawley | Brain - drug effects | Serotonin Plasma Membrane Transport Proteins - metabolism | Venlafaxine Hydrochloride | Protriptyline - pharmacology | Animals | Antidepressive Agents, Tricyclic - pharmacology | Norepinephrine Plasma Membrane Transport Proteins - metabolism | Serotonin Uptake Inhibitors - pharmacology
Journal Article
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 5/2004, Volume 101, Issue 21, pp. 8186 - 8191
Journal Article
Journal Article
American Journal of Physiology - Lung Cellular and Molecular Physiology, ISSN 1040-0605, 12/2011, Volume 301, Issue 6, pp. 937 - 944
Maternal use of selective serotonin (5-HT) reuptake inhibitors (SSRIs) is associated with an increased risk for persistent pulmonary hypertension of the... 
Gr127935 | Persistent pulmonary hypertension of the newborn | Sb206553 | Ketanserin | 5-HT1B RECEPTOR | PHYSIOLOGY | CONVERGING EVIDENCE | PRENATAL EXPOSURE | IN-UTERO EXPOSURE | SB206553 | persistent pulmonary hypertension of the newborn | RECEPTORS MEDIATING VASOCONSTRICTION | ketanserin | PREGNANCY | RHO-KINASE ACTIVATION | RESPIRATORY SYSTEM | ARTERIAL-HYPERTENSION | GR127935 | 5-HYDROXYTRYPTAMINE TRANSPORTER GENE | TRANSGENIC MICE | Serotonin - physiology | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine - analogs & derivatives | Hypertension, Pulmonary - physiopathology | Hysterotomy | Serotonin - pharmacology | rho-Associated Kinases - antagonists & inhibitors | Dose-Response Relationship, Drug | Oxadiazoles - pharmacology | Vascular Resistance - drug effects | Female | Indoles - pharmacology | Lung - metabolism | Fluoxetine - pharmacology | Ketanserin - pharmacology | Sertraline - pharmacology | Pulmonary Artery - drug effects | Serotonin 5-HT2 Receptor Antagonists - pharmacology | Piperazines - pharmacology | Receptors, Serotonin - metabolism | Fetus - drug effects | Pregnancy | Animals | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine - pharmacology | Sheep | Pyridines - pharmacology | Hemodynamics | Lung - blood supply | Serotonin Uptake Inhibitors - pharmacology | Physiological aspects | Fetus | Serotonin | Growth | Health aspects
Journal Article